Acute effects of iron-particle radiation on immunity. Part II: Leukocyte activation, cytokines and adhesion

Radiation Research

Volumn 165, Issue 1, 2006, Pages 78-87

  Gridley, Daila S ^a,b   Dutta Roy, Radha ^a   Andres, Melba L ^a   Nelson, Gregory A ^a   Pecaut, Michael J ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD3 ANTIGEN; CD71 ANTIGEN; CONCANAVALIN A; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR ALPHA; IRON; LIPOPOLYSACCHARIDE; MITOGENIC AGENT; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD CELL; CELL ASSAY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOMETRIC BEAD ARRAY ASSAY; CYTOMETRY; DNA SYNTHESIS; FEMALE; GRANULAR CELL; GRAVITY; IMMUNITY; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LINEAR ENERGY TRANSFER; LOW ENERGY RADIATION; MONONUCLEAR CELL; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEON; PARTICLE RADIATION; PRIORITY JOURNAL; RADIATION RESPONSE; SPACE FLIGHT; SPLEEN CELL; T LYMPHOCYTE; WHOLE BODY RADIATION;

ANIMALS; CELL ADHESION; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; IMMUNITY, NATURAL; IRON ISOTOPES; LEUKOCYTES; LINEAR ENERGY TRANSFER; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; RADIATION DOSAGE; WHOLE-BODY IRRADIATION;

ANIMALIA;

EID: 29644438451     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3490.1     Document Type: Article

References (49)

1. 132Te). Health Phys. 86, 565-585 (2004).
2. E. V. Polzik, V. L. Lezhnin and V. S. Kazantsev, Evaluation of radon effects on lung cancer development. Radiats. Biol. Radioecol. 44, 207-215 (2004).
3. E. Ron, Cancer risks from medical radiation. Health Phys. 85, 47-59 (2003).
4. T. K. Hei and E. J. Hall, In vitro oncogenic transformation at low doses and relevance to human cancer induction. In Cell Transformation Systems Relevant to Radiation-Induced Cancer in Man (K. H. Chadwick, B. Barnhart and C. Seymour, Eds.), pp. 349-355. Adam Hilger, New York, 1998.
5. R. J. M. Fry, P. Powers-Risius, E. L. Alpen, E. J. Ainsworth and R. L. Ullrich, High-LET radiation carcinogenesis. Adv. Space Res. 3, 241-248 (1983).
6. J. J. Broerse, L. A. Hennen, W. M. Klapwijk and H. A. Solleveld, Mammary carcinogenesis in different rat strains after irradiation and hormone administration. Int. J. Radiat. Biol. 51, 1091-1100 (1987).
7. F. J. Burns, Y. Jin, S. J. Garte and S. Hosselet, Estimation of risk based on multiple events in radiation carcinogenesis of rat skin. Adv. Space Res. 14, 507-519 (1994).
8. K. George, M. Durante, H. Wu, V. Willingham, G. Badhwar and F. A. Cucinotta, Chromosome aberrations in the blood lymphocytes of astronauts after space flight. Radiat. Res. 156, 731-738 (2001).
9. A. T. Lesnyak, G. Sonnenfeld, M. P. Rykova, D. O. Meshkov, A. Mastro and I. Konstantinova, Immune changes in test animals during spaceflight. J. Leukoc. Biol. 54, 214-226 (1993).
10. G. Sonnenfeld, J. S. Butel and W. T. Shearer, Effects of the space flight environment on the immune system. Rev. Environ. Health 18, 1-17 (2003).
11. J. W. Hadden, Immunodeficiency and cancer: Prospects for correction. Int. Immunopharmacol. 3, 1061-1071 (2003).
12. U. Duhrsen and D. Metcalf, Effects of irradiation of recipient mice on the behavior and leukemogenic potential of factor-dependent hematopoietic cell lines. Blood 75, 190-197 (1990).
13. D. S. Gridley, M. L. Andres and J. M. Slater, Enhancement of prostate cancer xenograft growth with whole-body radiation and vascular endothelial growth factor. Anticancer Res. 17, 923-928 (1997).
14. S. K. Mehta, R. P. Stowe, A. H. Feiveson, S. K. Tyring and D. L. Pierson, Reactivation and shedding of cytomegalovirus in astronauts during spaceflight. J. Infect. Dis. 182, 1761-1764 (2000).
15. R. P. Stowe, D. L. Pierson, D. L. Feeback and A. D. Barren, Stress-induced reactivation of Epstein-Barr virus in astronauts. Neuroimmunomodulation 3, 51-58 (2000).
16. R. F. Ambinder, Epstein-Barr virus-associated lymphoproliferative disorders. Rev. Clin. Exp. Hematol. 7, 362-374 (2003).
17. A. Pahari and L. Rees, BK virus-associated renal problems-clinical implications. Pediatr. Nephrol. 18, 743-748 (2003).
18. D. S. Gridley, M. J. Pecaut, L. M. Green, G. M. Miller and G. A. Nelson, Hypergravity-induced immunomodulation in a rodent model: Lymphocytes and lymphoid organs. J. Gravit. Physiol. 9, 15-27 (2002).
19. M. J. Pecaut, G. A. Nelson, R. Dutta-Roy and D. S. Gridley, Acute effects of iron-particle radiation on immunity. Part I: Population distribution. Radiat. Res. 165, 68-77 (2006).
20. D. S. Gridley, M. J. Pecaut and G. A. Nelson, Total-body irradiation with high-LET particles: Acute and chronic effects on the immune system. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, R677-R688 (2002).
21. M. J. Pecaut, G. A. Nelson, T. A. Bateman, L. S. Stodieck, S. J. Simske, L. L. Peters, S. Morony, P. J. Kostenuik and D. S. Gridley, Effects of spaceflight on immunity in the C57BL/6 mouse, Part I: Immune population distributions. J. Appl. Physiol. 94, 2085-2094 (2003).
22. C. Zeitlin, L. Heilbronn and J. Miller, Detailed characterization of the 1087 MeV/nucleon iron-56 beam used for radiobiology at the Alternating Gradient Synchrotron. Radiat. Res. 149, 560-569 (1998).
23. 56Fe in C, Al, Cu, Pb and CH2 targets. Phys. Rev. C 56, 388-397 (1997).
24. D. S. Gridley, G. A. Nelson, T. A. Bateman, L. S. Stodieck, S. J. Simske, L. L. Peters, S. Morony, P. J. Kostenuik and M. J. Pecaut, Effects of spaceflight on immunity in the C57BL/6 mouse, Part II: Activation, cytokines, erythrocytes, and platelets. J. Appl. Physiol. 94, 2095-2103 (2003).
25. D. S. Gridley, J. Li, E. H. Kajioka, R. Dutta-Roy, M. L. Andres, T. M. Timiryasova and I. Fodor, Lymphocyte activation with localized pGL1-TNF-alpha gene therapy in a glioma model. Oncology 62, 66-77 (2002).
26. E. H. Kajioka, C. Gheorghe, J. Li, M. L. Andres, J. Folz-Holbeck, G. A. Abell, J. M. Slater, G. A. Nelson and D. S. Gridley, Effects of proton and gamma radiation on lymphocyte populations and acute response to antigen. In Vivo 13, 525-533 (1999).
27. D. S. Gridley, M. J. Pecaut, G. M. Miller, M. F. Moyers and G. A. Nelson, Dose and dose rate effects of whole-body gamma-irradiation: II. Hematological variables and cytokines. In Vivo 15, 209-216 (2001).
28. E. H. Kajioka, M. L. Andres, X. W. Mao, M. F. Moyers, G. A. Nelson and D. S. Gridley, Hematological and TGF-β variations after whole-body proton irradiation. In Vivo 14, 703-708 (2000).
29. M. J. Pecaut, D. S. Gridley, A. L. Smith and G. A. Nelson, Dose and dose rate effects of whole-body proton-irradiation on lymphocyte blastogenesis and hematological variables: Part II. Immunol. Lett. 80, 67-73 (2002).
30. M. J. Pecaut, G. M. Miller, G. A. Nelson and D. S. Gridley, Hypergravity-induced immunomodulation in a rodent model: Hematological and lymphocyte function analyses. J. Appl. Physiol. 97, 29-38 (2004).
31. C. Koniaras, W. R. Heath and A. M. Lew, T cell unresponsiveness in vitro can be due to activation in vivo. Int. Immunol. 10, 365-369 (1998).
32. H. Ogawa and T. Tsunematsu, In vitro X-ray irradiation of human peripheral blood T lymphocytes enhances suppressor function. Clin. Exp. Immunol. 53, 444-450 (1983).
33. + regulatory T cell subsets. J. Leukoc. Biol. 74, 471-478 (2003).
34. B. B. Aggarwal, S. Shishodia, K. Ashikawa and A. C. Bharti, The role of TNF and its family members in inflammation and cancer: Lessons from gene deletion. Curr. Drug Targets Inflamm. Allergy 1, 327-341 (2002).
35. M. Drouet, F. Mourcin, N. Grenier, J. F. Mayol, V. Leroux, F. Herodin and J. J. Sotto, The effects of ionizing radiation on stem cells and hematopoietic progenitors: The place of apoptosis and the therapeutic potential of anti-apoptosis treatments. Can. J. Physiol. Pharmacol. 80, 700-709 (2002).
36. S. R. Moore, S. Marsden, D. Macdonald, S. Mitchell, M. Folkard, B. Michael, D. T. Goodhead, K. M. Prise and M. A. Kadhim, Genomic instability in human lymphocytes irradiated with individual charged particles: Involvement of tumor necrosis factor alpha in irradiated cells but not bystander cells. Radiat. Res. 163, 183-190 (2005).
37. + T cells is radiation sensitive. Cell. Immunol. 160, 248-256 (1995).
38. A. Merrick, F. Errington, K. Milward, D. O'Donnell, K. Harrington, A. Bateman, H. Pandha, R. Vile, E. Morrison, P. Selby and A. Melcher, Immunosuppressive effects of radiation on human dendritic cells: Reduced IL-12 production on activation and impairment of naive T-cell priming. Br. J. Cancer 92, 1450-1458 (2005).
39. J. Kipnis, H. Avidan, Y. Markovich, T. Mizrahi, E. Hauben, T. B. Prigozhina, S. Slavin and M. Schwartz, Low-dose gamma-irradiation promotes survival of injured neurons in the central nervous system via homeostasis-driven proliferation of T cells. Eur. J. Neurosci. 19, 1191-1198 (2004).
40. I. Shaked, Z. Porat, R. Gersner, J. Kipnis and M. Schwartz, Early activation of microglia as antigen-presenting cells correlates with T cell-mediated protection and repair of the injured central nervous system. J. Neuroimmunol. 146, 84-93 (2004).
41. N. P. Harrington, K. A. Chambers, W. M. Ross and L. G. Filion, Radiation damage and immune suppression in splenic mononuclear cell populations. Clin. Exp. Immunol. 107, 417-424 (1997).
42. V. Lesnikov, M. Lesnikova and H. J. Deeg, Pro-apoptotic and anti-apoptotic effects of transferrin and transferrin-derived glycans on hematopoietic cells and lymphocytes. Exp. Hematol. 29, 477-489 (2001).
43. D. Hallahan, J. Kuchibhotla and C. Wyble, Cell adhesion molecules mediate radiation-induced leukocyte adhesion to the vascular endothelium. Cancer Res. 56, 5150-5155 (1996).
44. A. Kawana, S. Shioya, H. Katoh, C. Tsuji, M. Tsuda and Y. Ohta, Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 on alveolar macrophages in the acute stage of radiation-induced lung injury in rats. Radiat. Res. 147, 431-436 (1997).
45. G. Pitsiou, G. Kyriazis, O. Hatzizisi, P. Argyropoulou, E. Mavrofridis and D. Patakas, Tumor necrosis factor-alpha serum levels, weight loss and tissue oxygenation in chronic obstructive pulmonary disease. Respir. Med. 96, 594-598 (2002).
46. H. Siggelkow, T. Eidner, G. Lehmann, V. Viereck, D. Raddatz, U. Munzel, G. Hein and M. Hufner, Cytokines, osteoprotegerin, and RANKL in vitro and histomorphometric indices of bone turnover in patients with different bone diseases. J. Bone Miner. Res. 18, 529-538 (2003).
47. M. Akiyama, O-L. Zhou, Y. Kusunoki, S. Kyoizumi, N. Kohno, S. Akiba and R. R. Delongchamp, Age- and dose-related alteration of in vitro mixed lymphocyte culture response of blood lymphocytes from A-bomb survivors. Radiat. Res. 117, 26-34 (1989).
48. N. Dainiak, Hematological consequences of exposure to ionizing radiation. Exp. Hematol. 30, 513-528 (2002).
49. Y. Kusunoki, T. Hayashi, Y. Morishita, M. Yamaoka, M. Maki, M. A. Bean, S. Kyoizumi, M. Hakoda and K. Kodama, T-cell responses to mitogens in atomic bomb survivors: A decreased capacity to produce interleukin 2 characterizes the T cells of heavily irradiated individuals. Radiat. Res. 155, 81-88 (2001).